



Bilateral  thalamic  involvement  has  been  suggested  as 
a  diagnostic  marker  of  sandhoff  disease.  A  case  of  an 
18-month-old  infant  admitted  for  psychomotor  regres-
sion  and  drug  resistant  myoclonic  epilepsy  is  presented. 
Cerebral CT scan showed bilateral and symmetrical tha-
lamic hyperdensity. MrI revealed that the thalamus was 
hyperintense  on T1-weighted  images  and  hypointense  on 
T2-weighted  images  with  a  hypersignal T2  of  the  white 
matter. Enzymatic assays objectified a deficiency of both 






order  caused  by  a  deficiency  of  both  hexosaminidases A 
and B resulting in accumulation of glycosphingolipids and 
oligosaccharides in the brain. It represents 7% of cases of 









inity of the first degree of the parents and the death of a 
brother at the age of 16 months under unspecified circums-
tances. The other brother and sister were unaffected.
The  onset  of  clinical  symptoms  began  at  the  age  of 





































sandhoff  diseases)  or  GM1  gangliosidosis  (e.g.  Landing 
disease), Canavan disease or Alexander disease.
Chromatography of amino acids in the blood, urine and 
cerebrospinal fluid (CSF) was normal and chromatography 
of organic acids in the urine was also normal. enzymatic 
assays were performed in France and revealed a deficiency 
of both hexosaminidases A and B confirming the diagnosis 
of sandhoff disease.
Discussion
sandhoff  disease  is  a  rare  autosomal  recessive  inherited 
metabolic disorder caused by mutations in the HEXB gene 







and  tonico-clonic  or  myoclonic  seizures,  blindness,  psy-
chomotor retardation and paralysis [1]. A cherry-red spot 


































the long fiber tracts of the pons through the crus cerebri.
recently, Lowe et al. found an additional 2.07 ppm reso-
nance in proton MrI spectra of the brain of sandhoff mice 
which could be identified as originating from N-acetylhe-
xosamine [8]. Wilken et al. reported similar proton Mrs 







tified in Tay-Sachs disease GM1 gangliosidoses and in late 




which are not observed in GM1 gangliosidoses. In Krab-




Diagnosis is confirmed by enzymatic assays revealing a 
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